Authorization

GenMark Diagnostics Schedules Third Quarter 2019 Financial Results Conference Call for November 6, 2019

CARLSBAD, Calif., Oct. 23, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) today announced that it plans to release its third quarter earnings results after market close onA Wednesday, November 6, 2019. Management will hold a conference call to review the company's financial performance starting atA 4:30 p.m. ETA on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on theA GenMark Diagnostics, Inc.A website atA www.genmarkdx.comA under the investor relations section and will be archived for future reference. To listen to the conference call, please dial (877) 312-5847 (US/Canada) or (253) 237-1154 (International) and use the conference ID number 2190875 approximately five minutes prior to the start time.
ABOUTA GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensorA® detection technology, GenMark's eSensor XT-8A® and ePlexA® systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMarka??s ePlex: The True Sample-to-Answer Solutiona?? is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections. For more information, visit www.genmarkdx.com.Investor Relations Contact
Leigh Salvo
(415) 937-5404
ir@genmarkdx.com
See also:
Leave a comment
News
  • Latest
  • Read
  • Commented
Calendar Content
«    Февраль 2020    »
ПнВтСрЧтПтСбВс
 12
3456789
10111213141516
17181920212223
242526272829